"Arguably the most oppositional team leader of the review board to the approval of Duchenne Muscular Dystrophy (DMD)-treating pipeline drug eteplirsen, has officially left the FDA."
Thank you for sharing this.
It says he left to work for Paraxel a pharmaceutical company that specializes in clinical trials. I wonder if they will be working on a treatment for DMD. Hmm.